» Articles » PMID: 38891946

Coexistence of Retinitis Pigmentosa and Ataxia in Patients with PHARC, PCARP, and Oliver-McFarlane Syndromes

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jun 19
PMID 38891946
Authors
Affiliations
Soon will be listed here.
Abstract

Retinitis pigmentosa (RP) is an inherited retinal dystrophy caused by the loss of photoreceptors and retinal pigment epithelial atrophy, leading to severe visual impairment or blindness. RP can be classified as nonsyndromic or syndromic with complex clinical phenotypes. Three unrelated Polish probands affected with retinitis pigmentosa coexisting with cerebellar ataxia were recruited for this study. Clinical heterogeneity and delayed appearance of typical disease symptoms significantly prolonged the patients' diagnostic process. Therefore, many clinical and genetic tests have been performed in the past. Here, we provide detailed clinical and genetic analysis results of the patients. Whole-exome sequencing (WES) and targeted NGS analysis allow the identification of four novel and two previously reported variants in the following genes: , , and The use of next-generation sequencing (NGS) methods finally allowed for confirmation of the clinical diagnosis. Ultra-rare diseases such as PHARC, PCARP, and Oliver-McFarlane syndromes were diagnosed in patients, respectively. Our findings confirmed the importance of the application of next-generation sequencing methods, especially in ultra-rare genetic disorders with overlapping features.

Citing Articles

A Novel Compound Heterozygous Variant in the ABHD12 Gene Cause PHARC Syndrome in a Chinese Family: The Proband Presenting New Genotype and Phenotype.

Ma M, Ma J, Lian Y, Wu X, Wang W, Rong W Mol Genet Genomic Med. 2025; 13(2):e70055.

PMID: 39910854 PMC: 11799048. DOI: 10.1002/mgg3.70055.

References
1.
Eisenberger T, Slim R, Mansour A, Nauck M, Nurnberg G, Nurnberg P . Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3. Orphanet J Rare Dis. 2012; 7:59. PMC: 3518140. DOI: 10.1186/1750-1172-7-59. View

2.
Fiskerstrand T, Hmida-Ben Brahim D, Johansson S, MZahem A, Haukanes B, Drouot N . Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism. Am J Hum Genet. 2010; 87(3):410-7. PMC: 2933347. DOI: 10.1016/j.ajhg.2010.08.002. View

3.
Chen D, Naydenov A, Blankman J, Mefford H, Davis M, Sul Y . Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects. Hum Mutat. 2013; 34(12):1672-8. PMC: 3855015. DOI: 10.1002/humu.22437. View

4.
McLaren W, Gil L, Hunt S, Riat H, Ritchie G, Thormann A . The Ensembl Variant Effect Predictor. Genome Biol. 2016; 17(1):122. PMC: 4893825. DOI: 10.1186/s13059-016-0974-4. View

5.
Klockgether T, Mariotti C, Paulson H . Spinocerebellar ataxia. Nat Rev Dis Primers. 2019; 5(1):24. DOI: 10.1038/s41572-019-0074-3. View